statistiche ricercatore

Continente	#
NA - Nord America	1.481
EU - Europa	1.155
AS - Asia	652
Continente sconosciuto - Info sul continente non disponibili	110
SA - Sud America	72
AF - Africa	16
OC - Oceania	9
Totale	3.495

Nazione	#
US - Stati Uniti d'America	1.442
PL - Polonia	431
IT - Italia	306
SG - Singapore	232
CN - Cina	138
DE - Germania	80
VN - Vietnam	78
SE - Svezia	67
BR - Brasile	58
FR - Francia	47
HK - Hong Kong	45
FI - Finlandia	37
GB - Regno Unito	32
IN - India	32
KR - Corea	30
NL - Olanda	30
CA - Canada	27
UA - Ucraina	27
RU - Federazione Russa	24
BD - Bangladesh	18
JP - Giappone	17
TR - Turchia	17
BE - Belgio	14
CZ - Repubblica Ceca	12
IE - Irlanda	12
BG - Bulgaria	10
IR - Iran	9
MA - Marocco	6
NZ - Nuova Zelanda	6
CH - Svizzera	5
ES - Italia	5
IQ - Iraq	5
SN - Senegal	5
MX - Messico	4
OM - Oman	4
PK - Pakistan	4
QA - Qatar	4
TT - Trinidad e Tobago	4
TW - Taiwan	4
AR - Argentina	3
AU - Australia	3
CO - Colombia	3
VE - Venezuela	3
AT - Austria	2
CL - Cile	2
EC - Ecuador	2
ID - Indonesia	2
IL - Israele	2
LT - Lituania	2
MY - Malesia	2
NO - Norvegia	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
EU - Europa	1
GR - Grecia	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
JO - Giordania	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
LC - Santa Lucia	1
MD - Moldavia	1
MK - Macedonia	1
NP - Nepal	1
PE - Perù	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
SI - Slovenia	1
SZ - Regno dello Swaziland	1
TH - Thailandia	1
ZA - Sudafrica	1
Totale	3.387

Nome	#
Mutant p53 improves cancer cells’ resistance to endoplasmic reticulum stress by sustaining activation of the UPR regulator ATF6	473
Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer	452
Complexes formed by mutant p53 and their roles in breast cancer	380
A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP	359
Tumor Suppressor DAB2IP as a target for post-transcriptional inactivation in cancer	331
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells	312
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer	303
Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP	231
The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells	187
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway	173
Cutting the Brakes on Ras - Cytoplasmic GAPs as Targets of Inactivation in Cancer	157
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications	137
Totale	3.495

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	150	0	0	16	10	8	10	9	4	11	16	20	46
2022/2023	216	15	34	21	36	15	33	7	18	24	8	1	4
2023/2024	227	9	19	8	6	20	41	44	43	3	4	23	7
2024/2025	481	11	37	67	60	38	25	19	45	31	65	43	40
2025/2026	936	117	29	50	81	70	78	165	26	93	132	52	43
2026/2027	100	22	48	30	0	0	0	0	0	0	0	0	0
Totale													3.495

ArTS Archivio della ricerca di Trieste